What would be the right regimen (exercise, nutrition, supplements, etc.) in order to not only minimize muscle tissue...

December 6, 2025Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case — no signup, answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Question asked:

What would be the right regimen (exercise, nutrition, supplements, etc.) in order to not only minimize muscle tissue loss (from ADT and GLP-1 therapies), but to build muscle in the absence of Testosterone.

Building Muscle During ADT and GLP-1 Therapy: Educational Framework

This is an excellent question that many cancer patients face. Let me explain the clinical reasoning, then provide questions to discuss with your care team.

How Doctors Think About This Challenge

The Clinical Problem:

  • ADT (Androgen Deprivation Therapy) suppresses testosterone, which normally supports muscle protein synthesis and muscle maintenance
  • GLP-1 medications (like semaglutide) promote weight loss by reducing appetite and increasing satiety, which can accelerate muscle loss if not carefully managed
  • Together, these create a "double hit" to muscle tissue that requires intentional intervention

The Medical Framework: Oncologists and supportive care specialists recognize that preserving lean muscle mass during these therapies improves:

  • Physical function and quality of life
  • Treatment tolerance
  • Long-term health outcomes
  • Metabolic health

General Approaches That Exist in Medical Literature

1. Resistance Exercise (Strength Training)

According to ASCO guidelines on cancer survivorship, resistance training is one of the most evidence-based interventions for preserving muscle during hormone therapy.

General approach:

  • Progressive resistance training (weights, resistance bands, bodyweight exercises)
  • 2-3 sessions per week targeting major muscle groups
  • Emphasis on compound movements (squats, chest press, rows, deadlifts)
  • Gradual progression in weight/resistance

2. Protein Nutrition

NCCN Cancer Survivorship Guidelines and American Cancer Society recommendations emphasize adequate protein intake during cancer treatment.

General approach:

  • Higher protein intake than sedentary individuals (typically 1.2-1.6g per kg of body weight daily)
  • Distributed across meals (not all at once)
  • Combination of animal and plant-based sources
  • Timing protein intake around exercise sessions

3. Aerobic Activity

  • Moderate aerobic exercise (walking, cycling, swimming) 150+ minutes weekly
  • Supports cardiovascular health and metabolic function
  • Complements resistance training

4. Nutritional Considerations During GLP-1 Use

  • Caloric intake adequate to support muscle building (not excessive caloric deficit)
  • Micronutrient sufficiency (vitamin D, B vitamins, minerals)
  • Hydration optimization

5. Supplements: Evidence-Based Perspective

Important caveat: Supplement use during cancer treatment requires oncologist approval due to potential interactions.

Generally studied options (with varying evidence):

  • Vitamin D: Often deficient; supports muscle function and bone health
  • Creatine monohydrate: Some evidence for muscle preservation in aging populations; requires doctor approval
  • Protein powder: Convenient protein source; not a substitute for whole foods
  • Omega-3 fatty acids: May support muscle protein synthesis; check for interactions with your medications

⚠️ Critical boundary: I cannot recommend specific supplements for YOUR situation—some may interact with ADT, GLP-1 medications, or other treatments.


Questions to Ask Your Healthcare Team

  1. "Given that I'm on both ADT and GLP-1 therapy, what's the recommended protein intake for me specifically, and should I track it?"

  2. "Is resistance training safe for me right now? Are there any limitations based on my specific cancer type or other health conditions?"

  3. "Should I work with a cancer-specialized dietitian or exercise physiologist? Do you have referrals?"

  4. "Are there any supplements I should consider or avoid given my current medications?"

  5. "How should I monitor whether my muscle-building efforts are working? (e.g., body composition testing, strength assessments)"

  6. "What are realistic expectations for muscle building while on ADT? Should my goals differ from someone not on hormone therapy?"


Authoritative Resources for Further Reading

  • NCCN Guidelines for Survivorship: Includes exercise and nutrition recommendations
  • American Cancer Society - Nutrition During Cancer Treatment: Evidence-based dietary guidance
  • ASCO Guideline on Exercise During Cancer Treatment: Specific recommendations for safety and effectiveness

This information is for educational purposes only. Always consult your healthcare team—particularly your oncologist, a cancer-specialized dietitian, and an exercise physiologist—for personalized medical advice and decisions about your specific regimen.

Ask Navis about your case

That answer is general. Ask about your specific situation — no signup, answered right here.

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

Related Questions

Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...

TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...

TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya

It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...

TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2